Nestle Puts Peanut-Allergy Treatment Palforzia Up for Sale, Bloomberg Reports
02 Março 2023 - 5:42AM
Dow Jones News
--Nestle SA has started a process to sell its peanut-allergy
treatment Palforzia, Bloomberg reports, citing unnamed sources.
--Initial bids are expected next month, but no final decision
has been made on the timing of any sale, Bloomberg reports.
--Nestle, which bought the maker of Palforzia in a $2.6 billion
deal in 2020 and recently announced a $2.1 billion impairment
charge on the medication, declined to comment.
Full story: https://bloom.bg/3y2fmuv
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
March 02, 2023 03:27 ET (08:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Nestle (PK) (USOTC:NSRGY)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Nestle (PK) (USOTC:NSRGY)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Nestle SA (PK) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Nestle SA (PK)